Received Feb 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | ND549 | — |
there was a leakage; Underdose; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete dose administered in a adult male patient who received Herpes zoster (Shingrix) (batch number ND549, expiry date 10-JUN-2027) for prophylaxis. On 13-FEB-2026, the patient received the 2nd dose of Shingrix. On 13-FEB-2026, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: Underdose). On an unknown date, the patient experienced product leakage (Verbatim: there was a leakage). The outcome of the incomplete dose administered and product leakage were not applicable. Additional Information: GSK Receipt Date: 13-FEB-2026 The reporter reported that after she administered a dose of Shingrix to a male patient and some of the medication was not administered, there was a leakage. The reported asked what the recommendations or patient needed to be revaccinated. The batch number was not provided upon follow- up with the reporter.